Scotiabank raised the firm’s price target on Delek US (DK) to $40 from $33 and keeps a Sector Perform rating on the shares. The firm believes Q3 results will have a “positive impact” on near-term share performance given improvement in wholesale and other supply, the analyst tells investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DK:
- Delek US price target raised to $53 from $43 at Wells Fargo
- Delek US price target raised to $39 from $36 at Piper Sandler
- Delek US Earnings Call: Strong Performance Amid Challenges
- Delek US Holdings Reports Strong Q3 2025 Financial Results
- Delek US reports Q3 adjusted EPS $7.13 vs. ($1.45) last year